Statins and Diabetes: The Good, the Bad, and the Unknown

Volume: 15, Issue: 2
Published: Jan 9, 2013
Abstract
The ability for statins to reduce major cardiovascular events and mortality has lead to this drug class being the most commonly prescribed in the world. In particular, the benefit of these drugs in type 2 diabetes (T2D) is well established. In February 2012, the Food and Drug Administration released changes to statin safety label to include that statins have been associated with increases in hemoglobin A1C and fasting serum glucose levels. This...
Paper Details
Title
Statins and Diabetes: The Good, the Bad, and the Unknown
Published Date
Jan 9, 2013
Volume
15
Issue
2
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.